Department of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
FEBS J. 2014 Feb;281(4):1017-28. doi: 10.1111/febs.12674. Epub 2014 Jan 15.
Modulation of autotaxin (ATX), the lysophospholipase D enzyme that produces lysophosphatidic acid, with small-molecule inhibitors is a promising strategy for blocking the ATX-lysophosphatidic acid signaling axis. Although discovery campaigns have been successful in identifying ATX inhibitors, many of the reported inhibitors target the catalytic cleft of ATX. A recent study provided evidence for an additional inhibitory surface in the hydrophobic binding pocket of ATX, confirming prior studies that relied on enzyme kinetics and differential inhibition of substrates varying in size. Multiple hits from previous high-throughput screening for ATX inhibitors were obtained with aromatic sulfonamide derivatives interacting with the hydrophobic pocket. Here, we describe the development of a ligand-based strategy and its application in virtual screening, which yielded novel high-potency inhibitors that target the hydrophobic pocket of ATX. Characterization of the structure-activity relationship of these new inhibitors forms the foundation of a new pharmacophore model of the hydrophobic pocket of ATX.
小分子抑制剂对自分泌酶(ATX)的调节,ATX 是产生溶血磷脂酸的溶脂酶,是阻断 ATX-溶血磷脂酸信号轴的一种很有前途的策略。虽然发现活动成功地鉴定了 ATX 抑制剂,但许多报道的抑制剂针对 ATX 的催化裂缝。最近的一项研究为 ATX 的疏水结合口袋中的另一个抑制表面提供了证据,证实了先前依赖于酶动力学和对大小不同的底物进行差异抑制的研究。先前针对 ATX 抑制剂的高通量筛选获得了多个芳香磺酰胺衍生物与疏水口袋相互作用的命中。在这里,我们描述了基于配体的策略的开发及其在虚拟筛选中的应用,该策略产生了针对 ATX 疏水口袋的新型高效抑制剂。这些新抑制剂的结构-活性关系的表征为 ATX 疏水口袋的新型药效基团模型奠定了基础。